Stock Research for LMNX

LMNX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LMNX Stock Chart & Research Data

The LMNX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LMNX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LMNX Due diligence Resources & Stock Charts

The LMNX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LMNX Detailed Price Forecast - CNN Money CNN View LMNX Detailed Summary - Google Finance
Yahoo View LMNX Detailed Summary - Yahoo! Finance Zacks View LMNX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LMNX Trends & Analysis - Trade-Ideas Barrons View LMNX Major Holders - Barrons
NASDAQ View LMNX Call Transcripts - NASDAQ Seeking View LMNX Breaking News & Analysis - Seeking Alpha
Spotlight View LMNX Annual Report - CompanySpotlight.com OTC Report View LMNX OTC Short Report - OTCShortReport.com
TradeKing View LMNX Fundamentals - TradeKing Charts View LMNX SEC Filings - Bar Chart
WSJ View Historical Prices for LMNX - The WSJ Morningstar View Performance/Total Return for LMNX - Morningstar
MarketWatch View the Analyst Estimates for LMNX - MarketWatch CNBC View the Earnings History for LMNX - CNBC
StockMarketWatch View the LMNX Earnings - StockMarketWatch MacroAxis View LMNX Buy or Sell Recommendations - MacroAxis
Bullish View the LMNX Bullish Patterns - American Bulls Short Pains View LMNX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LMNX Stock Mentions - StockTwits PennyStocks View LMNX Stock Mentions - PennyStockTweets
Twitter View LMNX Stock Mentions - Twitter Invest Hub View LMNX Investment Forum News - Investor Hub
Yahoo View LMNX Stock Mentions - Yahoo! Message Board Seeking Alpha View LMNX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LMNX - SECform4.com Insider Cow View Insider Transactions for LMNX - Insider Cow
CNBC View LMNX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LMNX - OTC Markets
Yahoo View Insider Transactions for LMNX - Yahoo! Finance NASDAQ View Institutional Holdings for LMNX - NASDAQ


Stock Charts

FinViz View LMNX Stock Insight & Charts - FinViz.com StockCharts View LMNX Investment Charts - StockCharts.com
BarChart View LMNX Stock Overview & Charts - BarChart Trading View View LMNX User Generated Charts - Trading View




Latest Financial News for LMNX


Luminex's (LMNX) Preliminary Q4 Results Cheer Investors
Posted on Wednesday January 09, 2019

Luminex (LMNX) likely to gain from strong segmental contributions in Q4.


Here's Why Investors Should Hold Luminex (LMNX) Stock Now
Posted on Monday January 07, 2019

Luminex (LMNX) gains from strength in the Aries platform. However, cutthroat competition in the life sciences industry is worrisome.


Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference
Posted on Monday January 07, 2019

AUSTIN, Texas, Jan. 7, 2019 /PRNewswire/ -- Luminex Corporation (LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the top of the previously communicated guidance range of $310 to $316 million. Total MDx revenue of approximately $164 million, up 1% over the full year 2017, inclusive of the departure of approximately $13 million of LabCorp non-CF revenue.  Total MDx revenue was up by approximately 13%, excluding the departure of LabCorp.


LMNX or PACB: Which is a Better MedTech Investment Pick?
Posted on Friday January 04, 2019

Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.